Q1 2021 Holdings
Filed 2021-05-17 | 151 holdings | $997.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $131.4M | 2,543,600 | 13.2% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $104.7M | 1,694,903 | 10.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $96.1M | 177,500 | 9.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $89.9M | 3,569,192 | 9.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $82.6M | 300,000 | 8.3% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $69.6M | 200,000 | 7.0% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $44.8M | 1,075,912 | 4.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $42.4M | 300,000 | 4.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $41.1M | 621,800 | 4.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $40.0M | 700,000 | 4.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $34.3M | 5,176,561 | 3.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $31.8M | 113,500 | 3.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $30.9M | 800,000 | 3.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $30.1M | 233,500 | 3.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $27.8M | 1,076,200 | 2.8% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $26.2M | 650,000 | 2.6% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $21.8M | 920,000 | 2.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $19.1M | 253,500 | 1.9% |
| Conmed Corp(CNMD) | COM | 207410101 | $11.1M | 85,085 | 1.1% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $10.1M | 781,569 | 1.0% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $8.2M | 1,545,000 | 0.8% |
| Humana Inc(HUM) | COM | 444859102 | $126.2K | 301,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $124.6K | 933,500 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $102.3K | 275,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $100.2K | 2,660,822 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $98.7K | 1,015,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $97.6K | 2,292,285 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $96.8K | 371,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $88.7K | 120,000 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $88.1K | 180,000 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $84.8K | 450,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $84.6K | 2,213,977 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $83.6K | 461,000 | 0.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $80.4K | 506,500 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $75.1K | 570,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $72.6K | 746,732 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $71.8K | 1,025,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $67.7K | 485,000 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $60.1K | 432,496 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $57.5K | 625,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $55.4K | 323,647 | 0.0% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $54.0K | 130,000 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $51.3K | 1,559,248 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $51.2K | 450,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $48.7K | 582,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $44.9K | 2,775,127 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $44.3K | 368,764 | 0.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $44.3K | 850,000 | 0.0% |
| Eargo Inc | COM | 270087109 | $42.5K | 851,671 | 0.0% |
| Covetrus Inc(CVETUSD) | COM | 22304C100 | $42.0K | 1,400,000 | 0.0% |